NASDAQ:VRTS - Virtus Investment Partners Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $257.75
  • Forecasted Upside: -0.87 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$260.00
▲ +3.36 (1.31%)
1 month | 3 months | 12 months
Get New Virtus Investment Partners Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VRTS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VRTS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$257.75
▼ -0.87% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Virtus Investment Partners in the last 3 months. The average price target is $257.75, with a high forecast of $315.00 and a low forecast of $154.00. The average price target represents a -0.87% upside from the last price of $260.00.
Buy
The current consensus among 4 contributing investment analysts is to buy stock in Virtus Investment Partners. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/27/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/25/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/24/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/23/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/21/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/19/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/15/2021Morgan StanleyLower Price TargetEqual Weight$298.00 ➝ $295.00Low
i
4/14/2021Morgan StanleyBoost Price TargetEqual Weight$275.00 ➝ $298.00Medium
i
4/8/2021Morgan StanleyBoost Price TargetEqual Weight$275.00 ➝ $298.00Medium
i
2/4/2021Morgan StanleyBoost Price TargetEqual Weight$256.00 ➝ $275.00Low
i
2/3/2021BarclaysBoost Price TargetPositive ➝ Overweight$280.00 ➝ $315.00Low
i
1/25/2021BarclaysBoost Price TargetOverweight$270.00 ➝ $280.00High
i
1/20/2021Morgan StanleyBoost Price TargetEqual Weight$250.00 ➝ $256.00Low
i
1/11/2021Morgan StanleyBoost Price TargetEqual Weight$190.00 ➝ $250.00Medium
i
10/27/2020Morgan StanleyBoost Price TargetEqual Weight$167.00 ➝ $190.00High
i
10/26/2020Piper SandlerBoost Price TargetOverweight$200.00 ➝ $267.00High
i
10/26/2020BarclaysBoost Price TargetOverweight$180.00 ➝ $215.00High
i
10/15/2020Piper SandlerBoost Price TargetOverweight$190.00 ➝ $200.00High
i
10/9/2020Morgan StanleyBoost Price TargetEqual Weight$159.00 ➝ $167.00Low
i
7/28/2020Morgan StanleyBoost Price TargetEqual Weight$133.00 ➝ $159.00Low
i
7/27/2020Piper SandlerBoost Price TargetOverweight$150.00 ➝ $185.00Low
i
7/27/2020BarclaysBoost Price TargetOverweight$150.00 ➝ $170.00High
i
7/17/2020BarclaysReiterated RatingBuy$150.00Medium
i
7/15/2020Morgan StanleyBoost Price TargetEqual Weight$128.00 ➝ $133.00Low
i
7/10/2020Bank of AmericaBoost Price TargetBuy$140.00 ➝ $154.00Low
i
7/2/2020Morgan StanleyBoost Price TargetEqual Weight$90.00 ➝ $128.00Medium
i
6/15/2020BarclaysBoost Price TargetOutperform ➝ Overweight$105.00 ➝ $118.00High
i
5/6/2020Morgan StanleyBoost Price TargetEqual Weight$85.00 ➝ $90.00Low
i
5/4/2020BarclaysBoost Price TargetOverweight$95.00 ➝ $105.00Low
i
4/16/2020BarclaysReiterated RatingBuy$95.00High
i
4/15/2020Morgan StanleyBoost Price TargetEqual Weight$82.00 ➝ $85.00High
i
4/8/2020Morgan StanleyLower Price TargetEqual Weight$105.00 ➝ $82.00Medium
i
Rating by Michael Cyprys at Morgan Stanley
3/23/2020Bank of AmericaLower Price TargetBuy$103.00 ➝ $74.00High
i
3/13/2020Morgan StanleyLower Price TargetEqual Weight$132.00 ➝ $105.00High
i
Rating by Michael Cyprys at Morgan Stanley
2/18/2020Piper SandlerBoost Price TargetOverweight$144.00 ➝ $155.00Low
i
2/3/2020Morgan StanleyBoost Price TargetEqual Weight$122.00 ➝ $132.00High
i
Rating by Michael Cyprys at Morgan Stanley
2/3/2020BarclaysUpgradeEqual Weight ➝ Overweight$128.00 ➝ $145.00High
i
Rating by Jeremy Campbell at Barclays PLC
1/23/2020BarclaysReiterated RatingHold$128.00Low
i
Rating by Jeremy Campbell at Barclays PLC
12/12/2019Morgan StanleyBoost Price TargetEqual Weight$115.00 ➝ $117.00Medium
i
Rating by Michael Cyprys at Morgan Stanley
12/11/2019BarclaysReiterated RatingHold$114.00Medium
i
Rating by Jeremy Campbell at Barclays PLC
10/14/2019Bank of AmericaUpgradeNeutral ➝ BuyMedium
i
10/9/2019BarclaysReiterated RatingHold$105.00High
i
10/8/2019Morgan StanleyLower Price TargetEqual Weight$108.00 ➝ $106.00High
i
Rating by Michael Cyprys at Morgan Stanley
10/8/2019Bank of AmericaLower Price TargetNeutral$123.00 ➝ $110.00High
i
8/5/2019Morgan StanleyLower Price TargetEqual Weight$118.00 ➝ $108.00Low
i
Rating by Michael Cyprys at Morgan Stanley
7/9/2019Morgan StanleyLower Price TargetEqual Weight$121.00 ➝ $118.00Medium
i
Rating by Michael Cyprys at Morgan Stanley
6/6/2019Bank of AmericaReiterated RatingNeutral ➝ Neutral$130.00 ➝ $118.00Low
i
Rating by Michael Carrier at Bank of America Co.
5/2/2019Morgan StanleySet Price TargetHold$121.00Low
i
Rating by Michael Cyprys at Morgan Stanley
4/26/2019Morgan StanleySet Price TargetHold$112.00Low
i
Rating by Michael Cyprys at Morgan Stanley
4/12/2019Bank of AmericaBoost Price TargetNeutral$119.00 ➝ $125.00Low
i
Rating by Michael Carrier at Bank of America Co.
4/9/2019Bank of AmericaSet Price TargetHold$119.00High
i
Rating by Michael Carrier at Bank of America Co.
2/19/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$90.00 ➝ $95.00Medium
i
2/8/2019Morgan StanleySet Price TargetHold$92.00Low
i
Rating by Michael Cyprys at Morgan Stanley
1/14/2019Credit Suisse GroupSet Price TargetOutperform$150.00 ➝ $113.00Medium
i
Rating by Ari Ghosh at Credit Suisse Group AG
12/20/2018Sandler O'NeillInitiated CoverageBuy$94.00Medium
i
Rating by Sumeet Mody at Sandler O'Neill
12/6/2018Bank of AmericaReiterated RatingNeutral ➝ Neutral$115.00 ➝ $100.00High
i
11/14/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$147.00 ➝ $111.00Low
i
Rating by Michael Cyprys at Morgan Stanley
10/29/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$140.00 ➝ $115.00Medium
i
10/29/2018Credit Suisse GroupSet Price TargetBuy$150.00Medium
i
Rating by Ari Ghosh at Credit Suisse Group AG
10/9/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Hold$145.00 ➝ $147.00Medium
i
7/30/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$132.00 ➝ $140.00Medium
i
7/30/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Buy$174.00 ➝ $175.00Medium
i
Rating by Ari Ghosh at Credit Suisse Group AG
7/13/2018Sandler O'NeillSet Price TargetHold$140.00Medium
i
Rating by Andrew Disdier at Sandler O'Neill
7/12/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$137.00 ➝ $144.00Low
i
4/30/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$130.00 ➝ $132.00Low
i
4/23/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$140.00 ➝ $130.00Low
i
4/11/2018Sandler O'NeillReiterated RatingHold$131.00Low
i
Rating by Andrew Disdier at Sandler O'Neill
4/10/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$136.00 ➝ $135.00Low
i
Rating by Michael Cyprys at Morgan Stanley
3/15/2018Sandler O'NeillReiterated RatingHold$142.00Medium
i
Rating by Andrew Disdier at Sandler O'Neill
2/12/2018Sandler O'NeillSet Price TargetHold$131.00Low
i
Rating by Andrew Disdier at Sandler O'Neill
2/7/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$127.00 ➝ $136.00Low
i
Rating by Michael Cyprys at Morgan Stanley
2/6/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$166.00 ➝ $173.00Low
i
2/5/2018Sandler O'NeillSet Price TargetHold$136.00High
i
Rating by Andrew Disdier at Sandler O'Neill
2/5/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$133.00 ➝ $140.00High
i
1/11/2018Sandler O'NeillSet Price TargetHold$132.00Medium
i
1/9/2018The Goldman Sachs GroupUpgradeSell ➝ Neutral$130.00N/A
i
10/30/2017BarclaysBoost Price TargetEqual Weight$116.00 ➝ $125.00N/A
i
10/23/2017Morgan StanleySet Price TargetNeutral ➝ Hold$122.00 ➝ $121.00N/A
i
Rating by Michael Cyprys at Morgan Stanley
10/10/2017Jefferies Financial GroupReiterated RatingHold$117.00 ➝ $127.00N/A
i
Rating by Surinder Thind at Jefferies Financial Group Inc.
10/10/2017BarclaysBoost Price TargetEqual Weight$113.00 ➝ $116.00N/A
i
10/9/2017Bank of AmericaUpgradeUnderperform ➝ Neutral$112.00 ➝ $130.00N/A
i
10/5/2017Morgan StanleySet Price TargetEqual Weight$120.00 ➝ $123.00N/A
i
Rating by Michael Cyprys at Morgan Stanley
9/8/2017BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$113.00Low
i
8/18/2017Jefferies Financial GroupReiterated RatingHold$117.00Low
i
Rating by Surinder Thind at Jefferies Financial Group Inc.
8/8/2017Credit Suisse GroupBoost Price TargetOutperform ➝ Neutral$141.00 ➝ $147.00Low
i
Rating by Ari Ghosh at Credit Suisse Group AG
7/31/2017Credit Suisse GroupUpgradeNeutral ➝ Outperform$141.00 ➝ $147.00High
i
7/17/2017Morgan StanleySet Price TargetHold$114.00 ➝ $110.00Low
i
7/10/2017Morgan StanleyReiterated RatingEqual Weight$105.00 ➝ $114.00Low
i
6/1/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$105.00Low
i
4/30/2017Jefferies Financial GroupSet Price TargetHold$110.00Low
i
Rating by Surinder Thind at Jefferies Financial Group Inc.
1/31/2017Bank of AmericaInitiated CoverageUnderperform ➝ Underperform$110.00N/A
i
1/11/2017Jefferies Financial GroupReiterated RatingHold$124.00N/A
i
11/7/2016Credit Suisse GroupReiterated RatingHold$110.00N/A
i
Rating by ari ghosh at Credit Suisse Group AG
10/31/2016Credit Suisse GroupDowngradeOutperform ➝ Neutral$104.00 ➝ $119.00N/A
i
Rating by ari ghosh at Credit Suisse Group AG
10/11/2016Jefferies Financial GroupBoost Price TargetHold$87.00 ➝ $97.00N/A
i
9/19/2016Credit Suisse GroupSet Price TargetBuy$104.00N/A
i
Rating by ari ghosh at Credit Suisse Group AG
8/8/2016Jefferies Financial GroupBoost Price TargetHold$74.00 ➝ $87.00N/A
i
Rating by Surinder Thind at Jefferies Financial Group Inc.
7/14/2016Credit Suisse GroupUpgradeNeutral ➝ Outperform$90.00 ➝ $91.00N/A
i
(Data available from 4/19/2016 forward)
Virtus Investment Partners logo
Virtus Investment Partners, Inc. is a publicly owned investment manager. The firm primarily provides its services to individual and institutional clients. It launches separate client focused equity and fixed income portfolios. The firm launches equity, fixed income, and balanced mutual funds for its clients. It invests in the public equity, fixed income, and real estate markets. The firm also invests in exchange traded funds. It employs a multi manager approach for its products. The firm employs quantitative analysis to make its investments. It benchmarks the performance of its portfolios against the S&P 500 Index. The firm conducts in-house research to make its investments. Virtus Investment Partners, Inc. was founded in 1988 and is based in Hartford, Connecticut.
Read More

Today's Range

Now: $260.00
$257.26
$264.64

50 Day Range

MA: $249.27
$234.72
$263.77

52 Week Range

Now: $260.00
$73.49
$270.00

Volume

53,300 shs

Average Volume

49,826 shs

Market Capitalization

$1.99 billion

P/E Ratio

39.22

Dividend Yield

1.26%

Beta

1.66

Frequently Asked Questions

What sell-side analysts currently cover shares of Virtus Investment Partners?

The following equities research analysts have issued research reports on Virtus Investment Partners in the last year: Bank of America Co., Barclays PLC, Morgan Stanley, Piper Sandler, and Zacks Investment Research.
View the latest analyst ratings for VRTS.

What is the current price target for Virtus Investment Partners?

4 Wall Street analysts have set twelve-month price targets for Virtus Investment Partners in the last year. Their average twelve-month price target is $257.75, suggesting a possible downside of 0.9%. Barclays PLC has the highest price target set, predicting VRTS will reach $315.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $154.00 for Virtus Investment Partners in the next year.
View the latest price targets for VRTS.

What is the current consensus analyst rating for Virtus Investment Partners?

Virtus Investment Partners currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VRTS will outperform the market and that investors should add to their positions of Virtus Investment Partners.
View the latest ratings for VRTS.

What other companies compete with Virtus Investment Partners?

How do I contact Virtus Investment Partners' investor relations team?

Virtus Investment Partners' physical mailing address is ONE FINANCIAL PLAZA, HARTFORD CT, 06103. The closed-end fund's listed phone number is 800-248-7971 and its investor relations email address is [email protected] The official website for Virtus Investment Partners is www.virtus.com.